From: Modelling the impact of improving screening and treatment of chronic hepatitis C virus infection on future hepatocellular carcinoma rates and liver-related mortality
Genotypes
1a
1 other
2
3a
3 other
Other
Distribution
23.0%
21.7%
5.7%
33.4%
12.5%
3.9%